Drug re-engineering and repurposing: A significant and rapid approach to tuberculosis drug discovery.

Reddy, Dinesh S; Sinha, Anamika; Kumar, Amit; Saini, Vipin K

Reddy, Dinesh S; Sinha, Anamika; Kumar, Amit; Saini, Vipin K.

Afiliación

Reddy DS; Centre for Nano and Material Sciences, Jain University, Bangalore, India.
Sinha A; Centre for Nano and Material Sciences, Jain University, Bangalore, India.
Kumar A; Centre for Nano and Material Sciences, Jain University, Bangalore, India.
Saini VK; Materials and Environmental Chemistry Research Laboratory, School of Environment & Natural Resources, Doon University, Dehradun, India.

Arch Pharm (Weinheim) ; 355(11): e2200214, 2022 Nov.

Article en En | MEDLINE | ID: mdl-35841594

Asunto(s)

COVID-19; Mycobacterium tuberculosis; Tuberculosis; Humanos; Reposicionamiento de Medicamentos; SARS-CoV-2; Relación Estructura-Actividad; Tuberculosis/tratamiento farmacológico; Antituberculosos/farmacología; Antituberculosos/química; Descubrimiento de Drogas

Palabras clave

drug discovery; re-engineering; repurposing; tuberculosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / COVID-19 / Mycobacterium tuberculosis Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Arch Pharm (Weinheim) Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google